Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors.

The global Oral Antidiabetic Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Oral Antidiabetic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Oral Antidiabetic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Oral Antidiabetic Agents in Home Use is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Oral Antidiabetic Agents include Novo Nordisk, Eli Lilly, Sanofi, Roche, Teva, AstraZeneca, Wockhardt UK, Merck and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Oral Antidiabetic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antidiabetic Agents.

Report Scope

The Oral Antidiabetic Agents market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Antidiabetic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Antidiabetic Agents companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oral Antidiabetic Agents Market Report

Report Metric	Details
Report Name	Oral Antidiabetic Agents Market
Segment by Type	Sulfonylureas Meglitinides Biguanides Thiazolidinediones Alpha-glucosidase Inhibitors
Segment by Application	Home Use Medical Institutions Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novo Nordisk, Eli Lilly, Sanofi, Roche, Teva, AstraZeneca, Wockhardt UK, Merck, Pfizer, Cipla
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Antidiabetic Agents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oral Antidiabetic Agents Market report?

Ans: The main players in the Oral Antidiabetic Agents Market are Novo Nordisk, Eli Lilly, Sanofi, Roche, Teva, AstraZeneca, Wockhardt UK, Merck, Pfizer, Cipla

What are the Application segmentation covered in the Oral Antidiabetic Agents Market report?

Ans: The Applications covered in the Oral Antidiabetic Agents Market report are Home Use, Medical Institutions, Others

What are the Type segmentation covered in the Oral Antidiabetic Agents Market report?

Ans: The Types covered in the Oral Antidiabetic Agents Market report are Sulfonylureas, Meglitinides, Biguanides, Thiazolidinediones, Alpha-glucosidase Inhibitors

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Sulfonylureas

1.2.3 Meglitinides

1.2.4 Biguanides

1.2.5 Thiazolidinediones

1.2.6 Alpha-glucosidase Inhibitors

1.3 Market by Application

1.3.1 Global Oral Antidiabetic Agents Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Home Use

1.3.3 Medical Institutions

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral Antidiabetic Agents Market Perspective (2019-2030)

2.2 Oral Antidiabetic Agents Growth Trends by Region

2.2.1 Global Oral Antidiabetic Agents Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Oral Antidiabetic Agents Historic Market Size by Region (2019-2024)

2.2.3 Oral Antidiabetic Agents Forecasted Market Size by Region (2025-2030)

2.3 Oral Antidiabetic Agents Market Dynamics

2.3.1 Oral Antidiabetic Agents Industry Trends

2.3.2 Oral Antidiabetic Agents Market Drivers

2.3.3 Oral Antidiabetic Agents Market Challenges

2.3.4 Oral Antidiabetic Agents Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oral Antidiabetic Agents Players by Revenue

3.1.1 Global Top Oral Antidiabetic Agents Players by Revenue (2019-2024)

3.1.2 Global Oral Antidiabetic Agents Revenue Market Share by Players (2019-2024)

3.2 Global Oral Antidiabetic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Oral Antidiabetic Agents Revenue

3.4 Global Oral Antidiabetic Agents Market Concentration Ratio

3.4.1 Global Oral Antidiabetic Agents Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic Agents Revenue in 2023

3.5 Oral Antidiabetic Agents Key Players Head office and Area Served

3.6 Key Players Oral Antidiabetic Agents Product Solution and Service

3.7 Date of Enter into Oral Antidiabetic Agents Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Antidiabetic Agents Breakdown Data by Type

4.1 Global Oral Antidiabetic Agents Historic Market Size by Type (2019-2024)

4.2 Global Oral Antidiabetic Agents Forecasted Market Size by Type (2025-2030)

5 Oral Antidiabetic Agents Breakdown Data by Application

5.1 Global Oral Antidiabetic Agents Historic Market Size by Application (2019-2024)

5.2 Global Oral Antidiabetic Agents Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Oral Antidiabetic Agents Market Size (2019-2030)

6.2 North America Oral Antidiabetic Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Oral Antidiabetic Agents Market Size by Country (2019-2024)

6.4 North America Oral Antidiabetic Agents Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oral Antidiabetic Agents Market Size (2019-2030)

7.2 Europe Oral Antidiabetic Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Oral Antidiabetic Agents Market Size by Country (2019-2024)

7.4 Europe Oral Antidiabetic Agents Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oral Antidiabetic Agents Market Size (2019-2030)

8.2 Asia-Pacific Oral Antidiabetic Agents Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Oral Antidiabetic Agents Market Size by Region (2019-2024)

8.4 Asia-Pacific Oral Antidiabetic Agents Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oral Antidiabetic Agents Market Size (2019-2030)

9.2 Latin America Oral Antidiabetic Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Oral Antidiabetic Agents Market Size by Country (2019-2024)

9.4 Latin America Oral Antidiabetic Agents Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oral Antidiabetic Agents Market Size (2019-2030)

10.2 Middle East & Africa Oral Antidiabetic Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Oral Antidiabetic Agents Market Size by Country (2019-2024)

10.4 Middle East & Africa Oral Antidiabetic Agents Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novo Nordisk

11.1.1 Novo Nordisk Company Detail

11.1.2 Novo Nordisk Business Overview

11.1.3 Novo Nordisk Oral Antidiabetic Agents Introduction

11.1.4 Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.1.5 Novo Nordisk Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Detail

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Oral Antidiabetic Agents Introduction

11.2.4 Eli Lilly Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.2.5 Eli Lilly Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Detail

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Oral Antidiabetic Agents Introduction

11.3.4 Sanofi Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.3.5 Sanofi Recent Development

11.4 Roche

11.4.1 Roche Company Detail

11.4.2 Roche Business Overview

11.4.3 Roche Oral Antidiabetic Agents Introduction

11.4.4 Roche Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.4.5 Roche Recent Development

11.5 Teva

11.5.1 Teva Company Detail

11.5.2 Teva Business Overview

11.5.3 Teva Oral Antidiabetic Agents Introduction

11.5.4 Teva Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.5.5 Teva Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Detail

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Oral Antidiabetic Agents Introduction

11.6.4 AstraZeneca Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.6.5 AstraZeneca Recent Development

11.7 Wockhardt UK

11.7.1 Wockhardt UK Company Detail

11.7.2 Wockhardt UK Business Overview

11.7.3 Wockhardt UK Oral Antidiabetic Agents Introduction

11.7.4 Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.7.5 Wockhardt UK Recent Development

11.8 Merck

11.8.1 Merck Company Detail

11.8.2 Merck Business Overview

11.8.3 Merck Oral Antidiabetic Agents Introduction

11.8.4 Merck Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.8.5 Merck Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Detail

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Oral Antidiabetic Agents Introduction

11.9.4 Pfizer Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.9.5 Pfizer Recent Development

11.10 Cipla

11.10.1 Cipla Company Detail

11.10.2 Cipla Business Overview

11.10.3 Cipla Oral Antidiabetic Agents Introduction

11.10.4 Cipla Revenue in Oral Antidiabetic Agents Business (2019-2024)

11.10.5 Cipla Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Oral Antidiabetic Agents Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Sulfonylureas

Table 3. Key Players of Meglitinides

Table 4. Key Players of Biguanides

Table 5. Key Players of Thiazolidinediones

Table 6. Key Players of Alpha-glucosidase Inhibitors

Table 7. Global Oral Antidiabetic Agents Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Oral Antidiabetic Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Oral Antidiabetic Agents Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Oral Antidiabetic Agents Market Share by Region (2019-2024)

Table 11. Global Oral Antidiabetic Agents Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Oral Antidiabetic Agents Market Share by Region (2025-2030)

Table 13. Oral Antidiabetic Agents Market Trends

Table 14. Oral Antidiabetic Agents Market Drivers

Table 15. Oral Antidiabetic Agents Market Challenges

Table 16. Oral Antidiabetic Agents Market Restraints

Table 17. Global Oral Antidiabetic Agents Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Oral Antidiabetic Agents Market Share by Players (2019-2024)

Table 19. Global Top Oral Antidiabetic Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Agents as of 2023)

Table 20. Ranking of Global Top Oral Antidiabetic Agents Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Oral Antidiabetic Agents Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Oral Antidiabetic Agents Product Solution and Service

Table 24. Date of Enter into Oral Antidiabetic Agents Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Oral Antidiabetic Agents Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Oral Antidiabetic Agents Revenue Market Share by Type (2019-2024)

Table 28. Global Oral Antidiabetic Agents Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Oral Antidiabetic Agents Revenue Market Share by Type (2025-2030)

Table 30. Global Oral Antidiabetic Agents Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Oral Antidiabetic Agents Revenue Market Share by Application (2019-2024)

Table 32. Global Oral Antidiabetic Agents Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Oral Antidiabetic Agents Revenue Market Share by Application (2025-2030)

Table 34. North America Oral Antidiabetic Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Oral Antidiabetic Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Oral Antidiabetic Agents Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Oral Antidiabetic Agents Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Oral Antidiabetic Agents Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Oral Antidiabetic Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Oral Antidiabetic Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Oral Antidiabetic Agents Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Oral Antidiabetic Agents Market Size by Country (2025-2030) & (US$ Million)

Table 49. Novo Nordisk Company Detail

Table 50. Novo Nordisk Business Overview

Table 51. Novo Nordisk Oral Antidiabetic Agents Product

Table 52. Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 53. Novo Nordisk Recent Development

Table 54. Eli Lilly Company Detail

Table 55. Eli Lilly Business Overview

Table 56. Eli Lilly Oral Antidiabetic Agents Product

Table 57. Eli Lilly Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 58. Eli Lilly Recent Development

Table 59. Sanofi Company Detail

Table 60. Sanofi Business Overview

Table 61. Sanofi Oral Antidiabetic Agents Product

Table 62. Sanofi Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 63. Sanofi Recent Development

Table 64. Roche Company Detail

Table 65. Roche Business Overview

Table 66. Roche Oral Antidiabetic Agents Product

Table 67. Roche Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 68. Roche Recent Development

Table 69. Teva Company Detail

Table 70. Teva Business Overview

Table 71. Teva Oral Antidiabetic Agents Product

Table 72. Teva Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 73. Teva Recent Development

Table 74. AstraZeneca Company Detail

Table 75. AstraZeneca Business Overview

Table 76. AstraZeneca Oral Antidiabetic Agents Product

Table 77. AstraZeneca Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 78. AstraZeneca Recent Development

Table 79. Wockhardt UK Company Detail

Table 80. Wockhardt UK Business Overview

Table 81. Wockhardt UK Oral Antidiabetic Agents Product

Table 82. Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 83. Wockhardt UK Recent Development

Table 84. Merck Company Detail

Table 85. Merck Business Overview

Table 86. Merck Oral Antidiabetic Agents Product

Table 87. Merck Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 88. Merck Recent Development

Table 89. Pfizer Company Detail

Table 90. Pfizer Business Overview

Table 91. Pfizer Oral Antidiabetic Agents Product

Table 92. Pfizer Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 93. Pfizer Recent Development

Table 94. Cipla Company Detail

Table 95. Cipla Business Overview

Table 96. Cipla Oral Antidiabetic Agents Product

Table 97. Cipla Revenue in Oral Antidiabetic Agents Business (2019-2024) & (US$ Million)

Table 98. Cipla Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Oral Antidiabetic Agents Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Oral Antidiabetic Agents Market Share by Type: 2023 VS 2030

Figure 3. Sulfonylureas Features

Figure 4. Meglitinides Features

Figure 5. Biguanides Features

Figure 6. Thiazolidinediones Features

Figure 7. Alpha-glucosidase Inhibitors Features

Figure 8. Global Oral Antidiabetic Agents Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Oral Antidiabetic Agents Market Share by Application: 2023 VS 2030

Figure 10. Home Use Case Studies

Figure 11. Medical Institutions Case Studies

Figure 12. Others Case Studies

Figure 13. Oral Antidiabetic Agents Report Years Considered

Figure 14. Global Oral Antidiabetic Agents Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Oral Antidiabetic Agents Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Oral Antidiabetic Agents Market Share by Region: 2023 VS 2030

Figure 17. Global Oral Antidiabetic Agents Market Share by Players in 2023

Figure 18. Global Top Oral Antidiabetic Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Agents as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Oral Antidiabetic Agents Revenue in 2023

Figure 20. North America Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Oral Antidiabetic Agents Market Share by Country (2019-2030)

Figure 22. United States Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Oral Antidiabetic Agents Market Share by Country (2019-2030)

Figure 26. Germany Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Oral Antidiabetic Agents Market Share by Region (2019-2030)

Figure 34. China Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Oral Antidiabetic Agents Market Share by Country (2019-2030)

Figure 42. Mexico Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Oral Antidiabetic Agents Market Share by Country (2019-2030)

Figure 46. Turkey Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Oral Antidiabetic Agents Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 49. Eli Lilly Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 50. Sanofi Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 51. Roche Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 52. Teva Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 53. AstraZeneca Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 54. Wockhardt UK Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 55. Merck Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 56. Pfizer Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 57. Cipla Revenue Growth Rate in Oral Antidiabetic Agents Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions